• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

父母对儿科镰状细胞病研究参与的态度。

Parental attitudes toward research participation in pediatric sickle cell disease.

机构信息

Division of Hematology, Oncology & Stem Cell Transplant, Children's Memorial Hospital, Chicago, Illinois, USA.

出版信息

Pediatr Blood Cancer. 2010 Jul 15;55(1):129-33. doi: 10.1002/pbc.22450.

DOI:10.1002/pbc.22450
PMID:20213846
Abstract

BACKGROUND

Socio-cultural attitudes and perceptions are commonly cited barriers to the recruitment of African-Americans for medical research, yet no studies have examined the factors influencing research participation among individuals with sickle cell disease (SCD) or caregivers of children with SCD.

PROCEDURE

We distributed a 32-item, self-administered survey to parents or legal guardians of children with SCD over a 6-month period. We used Pearson's chi-square to determine factors associated with a favorable attitude toward research participation and logistic regression to determine independent associations.

RESULTS

We collected 151 surveys in this pilot study. In general, 86% of respondents believed more research needed to be done for SCD and 57% would allow their child to participate in a medical research study, corresponding to a favorable attitude. Respondent belief that more research needed to be done for SCD (OR 23.4, 95% CI 4.5-121.9, P = 0.001), perception of greater severity of their own child's SCD (OR 2.7, 95% CI 1.0-7.1, P = 0.041) and prior exposure to research (OR 3.2, 95% CI 1.0-10.3, P = 0.043) were significantly associated with a favorable attitude, although only the first two remained independent associations in our regression model. Attitude toward research participation was not affected by respondent country of birth.

CONCLUSIONS

Parents of children with SCD who allow participation in medical research are likely to believe that more research is needed in SCD and that their child's SCD is moderate to severe. Developing effective tools, based on identified knowledge gaps related to clinical research, may improve research participation in this population.

摘要

背景

社会文化态度和观念通常被认为是招募非裔美国人参与医学研究的障碍,但尚无研究探讨影响镰状细胞病(SCD)患者或其患儿照顾者参与研究的因素。

方法

我们在 6 个月的时间内向 SCD 患儿的父母或法定监护人发放了一份包含 32 个项目的自填式调查问卷。我们使用 Pearson's chi-square 检验来确定与对研究参与持有利态度相关的因素,并使用 logistic 回归分析来确定独立关联因素。

结果

在这项初步研究中,我们共收集了 151 份调查问卷。总体而言,86%的受访者认为需要针对 SCD 开展更多的研究,57%的受访者愿意让自己的孩子参与医学研究,这表明他们对研究持有利态度。受访者认为需要针对 SCD 开展更多的研究(OR 23.4,95%CI 4.5-121.9,P = 0.001)、认为自己孩子的 SCD 更为严重(OR 2.7,95%CI 1.0-7.1,P = 0.041)以及先前接触过研究(OR 3.2,95%CI 1.0-10.3,P = 0.043)与对研究持有利态度显著相关,但在我们的回归模型中,仅有前两个因素为独立关联因素。受访者的出生国对研究参与态度没有影响。

结论

允许孩子参与医学研究的 SCD 患儿父母很可能认为 SCD 需要开展更多的研究,并且他们的孩子的 SCD 病情较为严重或非常严重。基于与临床研究相关的已识别知识差距开发有效的工具,可能会提高该人群对研究的参与度。

相似文献

1
Parental attitudes toward research participation in pediatric sickle cell disease.父母对儿科镰状细胞病研究参与的态度。
Pediatr Blood Cancer. 2010 Jul 15;55(1):129-33. doi: 10.1002/pbc.22450.
2
Public attitudes regarding willingness to participate in medical research studies.公众对参与医学研究的意愿所持的态度。
J Health Soc Policy. 2000;12(2):23-43. doi: 10.1300/J045v12n02_02.
3
Behavioral and emotional problems in children with sickle cell disease and healthy siblings: Multiple informants, multiple measures.镰状细胞病患儿及其健康兄弟姐妹的行为和情绪问题:多渠道信息提供者,多种测量方法。
Pediatr Blood Cancer. 2009 Dec 15;53(7):1277-83. doi: 10.1002/pbc.22257.
4
Dental screening and referral of young children by pediatric primary care providers.儿科初级保健提供者对幼儿进行牙科筛查和转诊。
Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269.
5
Parents' responses to symptoms of respiratory tract infection in their children.父母对其子女呼吸道感染症状的反应。
CMAJ. 2003 Jan 7;168(1):25-30.
6
Therapy preference and decision-making among patients with severe sickle cell anemia and their families.重度镰状细胞贫血患者及其家庭的治疗偏好与决策
Pediatr Blood Cancer. 2007 Jun 15;48(7):705-10. doi: 10.1002/pbc.20903.
7
Knowledge, attitudes and beliefs of primary caretakers towards sickle cell anaemia in children.儿童镰状细胞贫血症的主要照料者的知识、态度和信念
East Afr Med J. 1997 Jul;74(7):416-9.
8
Decision-making by adolescents and parents of children with cancer regarding health research participation.青少年和癌症患儿家长在健康研究参与方面的决策。
Pediatrics. 2009 Sep;124(3):959-65. doi: 10.1542/peds.2008-2878. Epub 2009 Aug 10.
9
Children's and their parents' views on facing research risks for the benefit of others.儿童及其父母对于为他人利益而面对研究风险的看法。
Arch Pediatr Adolesc Med. 2008 Jan;162(1):9-14. doi: 10.1001/archpediatrics.2007.3.
10
Caregiving time in sickle cell disease: psychological effects in maternal caregivers.镰状细胞病的护理时间:对母亲护理者的心理影响
Pediatr Blood Cancer. 2007 Jan;48(1):64-71. doi: 10.1002/pbc.20792.

引用本文的文献

1
Exploring How Children and Young People With Sickle Cell Disease and Their Families Want to be Involved in Research: A Qualitative Study.探索镰状细胞病儿童和青少年及其家庭希望如何参与研究:一项定性研究。
Health Expect. 2025 Apr;28(2):e70242. doi: 10.1111/hex.70242.
2
Health-related quality of life with standard and curative therapies in thalassemia: A narrative literature review.地中海贫血症标准和根治疗法的健康相关生活质量:叙事文献综述。
Ann N Y Acad Sci. 2024 Feb;1532(1):50-62. doi: 10.1111/nyas.15100. Epub 2024 Jan 25.
3
Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease.
利用实施研究综合框架识别小儿镰状细胞病共享决策随机临床试验的招募障碍和针对性策略。
Clin Trials. 2023 Jun;20(3):211-222. doi: 10.1177/17407745231154199. Epub 2023 Feb 16.
4
Clinical trial considerations in sickle cell disease: patient-reported outcomes, data elements, and the stakeholder engagement framework.镰状细胞病临床试验考虑因素:患者报告结局、数据要素和利益相关者参与框架。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):196-205. doi: 10.1182/hematology.2021000252.
5
Effective Recruitment Strategies for a Sickle Cell Patient Registry Across Sites from the Sickle Cell Disease Implementation Consortium (SCDIC).从镰状细胞疾病实施联盟(SCDIC)跨越站点的镰状细胞患者登记处的有效招募策略。
J Immigr Minor Health. 2021 Aug;23(4):725-732. doi: 10.1007/s10903-020-01102-6. Epub 2020 Oct 9.
6
Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research.对儿童镰状细胞病临床试验研究的不信任
Am J Prev Med. 2016 Jul;51(1 Suppl 1):S78-86. doi: 10.1016/j.amepre.2016.01.024.
7
Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov.对ClinicalTrials.gov注册的镰状细胞病介入试验的系统评价。
Clin Trials. 2015 Dec;12(6):575-83. doi: 10.1177/1740774515590811. Epub 2015 Jun 17.
8
Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell anemia.在一项镰状细胞贫血患儿的多中心临床试验中,随机分组与社会经济和人口统计学因素无关。
Pediatr Blood Cancer. 2014 Sep;61(9):1529-1535. doi: 10.1002/pbc.25072. Epub 2014 Apr 22.
9
Attitudes toward clinical trials among patients with sickle cell disease.镰状细胞病患者对临床试验的态度。
Clin Trials. 2014 Jun;11(3):275-283. doi: 10.1177/1740774513519876.
10
Views of adolescents and parents on pediatric research without the potential for clinical benefit.青少年和家长对无临床获益的儿科研究的看法。
Pediatrics. 2012 Oct;130(4):692-9. doi: 10.1542/peds.2012-0068. Epub 2012 Sep 10.